About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 965 record(s)
Req # A-2019-001917
Adverse Drug Reaction (ADR). Report number: E2B_02737965.Organization: Health Canada
March 2023
Req # A-2022-001311
Adverse Drug Reactions (ADRs) for REXULTI, ARIPIPRAZOLE. Report numbers: E2B_05795715, E2B_05717142, E2B_05720816. ADR for REXULTI. Report number: E2B_05723433. ADRs for ABILIFY MAINTENA, ARIPIPRAZOLE. Report numbers: E2B_05724504, E2B_05717118.Organization: Health Canada
March 2023
Req # A-2022-001406
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-110432-515, What We Heard Report During the 2022 Consultations on the Targeted Review of the Pest Control Products Act.Organization: Health Canada
March 2023
Req # A-2022-001434
Adverse Drug Reaction (ADR) for SOLIRIS. Report number: E2B_05935628.Organization: Health Canada
March 2023
Req # A-2022-00779
Copies of all briefing from January 1, 2022 to December 6, 2022 prepared for the Minister of Justice and the Deputy Minister regarding to the Ontario Coroner's Inquest into the Deaths of {Nathalie Warmerdam, Anastasia Kuzyk, and Carol Culleton…Organization: Department of Justice Canada
February 2023
Req # A-2022-000016
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-101391-582, Evaluation of the National COVID-19 Exposure Notification App.Organization: Health Canada
February 2023
Req # A-2022-000471
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-105985-788, Deputy Ministerial Meeting with the Health Research Foundation.Organization: Health Canada
February 2023
Req # A-2022-000677
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-107558-330, Deputy Ministerial Meeting with the Patented Medicine Prices Review Board.Organization: Health Canada
February 2023
Req # A-2022-001086
Adverse Drug Reactions (ADRs) for ABILIFY MAINTENA. Report numbers: E2B_05664957, E2B_05664982, E2B_05665009, E2B_05665010, E2B_05651560, E2B_05662861, E2B_05662992, E2B_05662994.Organization: Health Canada
February 2023
Req # A-2022-001090
Adverse Drug Reaction (ADR). Report number: E2B_05211145.Organization: Health Canada
February 2023